David E. Cohen
Insider Reports History
- Location
- Palo Alto, CA
- Signature
- /s/ Gregory S. Moss, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by David E. Cohen:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Timber Pharmaceuticals, Inc. | Director | Common Stock, par value $0.001 per share | 6,100 | $9,937 | $1.63 | 15 Apr 2023 | Direct |
| Evommune, Inc. | Director | Stock Option (Right to Buy) | 37,960 | 05 Nov 2025 | Direct | ||
| Evommune, Inc. | Director | Common Stock | 23,665 | 07 Nov 2025 | Direct | ||
| Timber Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 4,100 | 15 Apr 2023 | Direct | ||
| Evommune, Inc. | Director | Series Seed Preferred Stock | 0 | 07 Nov 2025 | Direct | ||
| Kadmon Holdings, Inc. | Director | Stock Option (right to buy) | 0 | $5.54 | 09 Nov 2021 | Direct |